Bill
LD 480
Expands MaineCare to cover certain weight-loss drugs, boosting access for enrollees while leaving criteria unclear; the measure is unlikely to advance this session.
LD 480: An Act To Support Healthy Weight By Providing Mainecare Coverage For Certain Weight Loss Medications
Overview
- Purpose: Proposes to expand MaineCare (Maine’s Medicaid program) to provide coverage for certain weight loss medications, with the goal of supporting healthy weight and related health outcomes.
- Status: As introduced, the bill progressed through a formal committee process but did not advance. Current status is "Reported Out - ONTP" and later listed as "DEAD" in Legislative Files under Joint Rule 310.3, meaning it is unlikely to proceed in its current form during the 2025 session.
- Introduced: February 6, 2025
- Primary subject: MaineCare, Medicaid, weight reduction medications
What the bill would do (as introduced)
- Expand MaineCare coverage to include certain weight loss medications. The summary provided does not include detailed criteria, specific medications, or coverage terms.
Key provisions and changes (availability of details)
- Specific coverage criteria, eligible medications, prior authorization requirements, copayments/cost-sharing, annual or lifetime caps, and implementation timelines are not provided in the materials given. The core concept is expansion of MaineCare to cover weight loss pharmacotherapy.
Who would be affected
- MaineCare enrollees seeking pharmacologic weight management would potentially gain access to the covered medications.
- Healthcare providers who treat obesity or overweight-related conditions (e.g., physicians, nurse practitioners, obesity specialists) and pharmacies that dispense covered medications would be affected.
- The MaineCare program and the state budget would face any associated cost, administrative requirements, and potential savings from improved health outcomes, subject to the bill’s final provisions.
Procedural and timeline notes
- 2025-02-06: Referred to the Committee on Health and Human Services; ordered printed under Joint Rule 401.
- 2025-03-11: Work session held; voted ONTP (Ought Not To Pass).
- 2025-03-20: Reported Out - ONTP; Placed in Legislative Files (DEAD) per Joint Rule 310.3.
- The "ONTP" and subsequent "DEAD" status indicate the bill did not advance to a full chamber vote and is unlikely to become law in its current form.
Context and implications
- If enacted, the bill could affect the availability of pharmacologic weight management options for low-income residents enrolled in MaineCare, with potential long-term implications for obesity-related health costs and chronic disease risk.
- As currently described, the bill lacks detailed implementing language. Stakeholders may need to review future amendments, fiscal notes, and policy specifics to assess budget impact and program design.
Next steps for interested readers
- Monitor updates on MaineCare coverage policy, obesity treatment initiatives, and any reintroductions or amendments in subsequent sessions.
- Review fiscal notes or bill text in future versions for specifics on eligibility, medications covered, cost-sharing, and implementation timelines.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
